Company / PP&E (Net)
PLIANT THERAPEUTICS, INC. PP&E (Net) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$2.9M
FY2025
5-year range
$2.9M / $5.5M
FY2021-FY2025
Trend
-46.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E (Net) has fluctuated over the past 6 years, ranging from $3M in FY2025 to $6M in FY2024.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of -7.4%.
Declined from $4M to $3M over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -13.1%
- 5-Year CAGR
- -7.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -7.4%, indicating a declining trend.
- In FY2025, pp&e (net) decreased 46.8% year-over-year.
- Peak pp&e (net) was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score -4.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.9M | -46.8% |
| FY2024 | $5.5M | +54.9% |
| FY2023 | $3.6M | -20.5% |
| FY2022 | $4.5M | -2.6% |
| FY2021 | $4.6M | +6.6% |
| FY2020 | $4.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026